Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Having patients directly pay for single-dose vials of Zepbound also "enables a transparent price by removing third-party supply chain entities," the company added in a release
In contrast, Ultomiris failed to significantly improve event-free survival over placebo in adults and adolescents with HSCT-TMA, marking the latest setback for AstraZeneca's pipeline after a failed heart disease trial earlier this month and an FDA advisory committee voted against approving its breast cancer therapy in May
Most begin to see meaningful results between weeks four and eight, and many reach their goal weight by weeks 17 to 20
( b,d )
US$ 24.43
US$ 22.61
US$ 24.66
